Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

LGNDLGND
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in LIGAND PHARMACEUTICALS

BNP PARIBAS FINANCIAL MARKETS holds 94,072 shares of LGND (LIGAND PHARMACEUTICALS), worth $29.7M as of 2026-Q2. The position was increased (+169.4% shares). LGND represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$29.7M

Current Shares

94,072

Total Value Change

+$29.3M

Total Shares Change

+89,916

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
94,072
+169.4%
$29.7M0.0%$316.09
46
2026-Q1
Decreased
34,915
-0.1%
$7M0.0%$204.24
0
2025-Q4
Increased
34,957
+754.3%
$6.6M0.0%$190.20
44
2025-Q3
Increased
4,092
+95.2%
$724,8570.0%$173.13
39
2025-Q2
Increased
2,096
+48.0%
$238,2730.0%$114.15
32
2025-Q1
Decreased
1,416
-41.7%
$148,8780.0%$107.62
0
2024-Q4
Decreased
2,428
-41.6%
$260,1600.0%$105.76
0
2024-Q3
Decreased
4,156
-27.6%
$415,9740.0%$97.37
0

Other major holders of LGND: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used